Metastatic melanoma (often called stage IV melanoma or advanced melanoma) means melanoma cells have moved beyond the original skin spot and nearby lymph nodes to distant parts of the bodycommonly the lungs, liver, brain, bones, or distant skin and lymph nodes. It’s a serious diagnosis, but it’s no longer the automatic “nothing works” situation people used to fear. Thanks to modern immunotherapy, targeted therapy, and smarter combinations of treatments, many people are living longerand some achieve long-lasting remission.

In this guide, we’ll walk through the symptoms you might notice, how doctors confirm the diagnosis, the most common treatment options, and what the outlook can realistically look like today. I’ll keep it clear, practical, and just slightly less terrifying than a late-night symptom search spiral. (You’re welcome.)

What “metastatic melanoma” actually means

Melanoma begins in melanocytescells that make pigment in your skin. When it’s caught early, melanoma is often treatable with surgery alone. But melanoma is also skilled at traveling. If cancer cells break away and spread through lymph fluid or the bloodstream, they can form new tumors elsewhere. That’s metastasis.

Metastatic melanoma can appear in a few scenarios:

• Recurrence after earlier treatment: A melanoma removed years ago can return and spread later.
• Advanced at diagnosis: Some people first learn they have melanoma only after symptoms show up in another organ.
• Unknown primary: In rarer cases, doctors find metastatic melanoma but can’t locate the original skin tumor.

Doctors may also describe melanoma using staging terms like “unresectable” (not removable with surgery) or “resectable” (removable). These details matter because they help shape the treatment plan.

Symptoms of metastatic melanoma

Here’s the tricky part: metastatic melanoma symptoms vary depending on where the cancer has spreadand some people have few symptoms at first. That’s why follow-up care after an earlier melanoma matters.

General symptoms (can happen with many cancers)

• Unusual fatigue that doesn’t match your schedule
• Unexplained weight loss
• Loss of appetite
• Persistent aches or a general “something’s off” feeling

Skin and lymph node symptoms

• New lumps under the skin (sometimes firm, painless nodules)
• Swollen lymph nodes (neck, armpit, groin) that don’t go down
• New or changing pigmented spotsespecially if you’ve had melanoma before

Symptoms based on where melanoma spreads

Lungs

• Shortness of breath
• Cough that doesn’t go away
• Chest discomfort

Liver

• Right-sided abdominal discomfort or swelling
• Loss of appetite, nausea
• Yellowing of skin or eyes (jaundice)

Brain

• New or worsening headaches
• Vision changes, dizziness, balance issues
• Weakness on one side, confusion, seizures

Bones

• Persistent bone pain (often worse at night)
• Fractures from minimal trauma

Important: These symptoms can have many causes that are not cancer. But if you’ve had melanoma beforeor you have a suspicious skin lesion nowpersistent symptoms deserve prompt medical attention.

How metastatic melanoma is diagnosed and staged

Diagnosing metastatic melanoma usually involves confirming two things: (1) yes, this is melanoma, and (2) where has it spread?

Common tests and steps

• Biopsy: A tissue sample from a skin spot, lymph node, or metastatic site confirms melanoma under a microscope.
• Imaging: CT, PET/CT, MRI (especially brain MRI), and sometimes ultrasound help map where disease is located.
• Blood tests: Doctors may check general health markers and sometimes LDH (lactate dehydrogenase), which can be linked to prognosis in stage IV melanoma.
• Molecular testing: Tumor testing for mutations (like BRAF V600) helps determine whether targeted therapy is an option.

Staging for melanoma is complex, but “metastatic” generally aligns with stage IV. Some stage III cases can be very advanced too, especially if they can’t be removed with surgery. Your care team will often talk in terms of “treatment approach” (first-line, second-line, etc.) rather than only stage numbers.

Treatment options for metastatic melanoma

The best treatment depends on where the melanoma is, how fast it’s growing, whether it has certain mutations, and what your overall health allows. Many people receive systemic therapy (medicine that treats the whole body). Some also benefit from surgery or radiation for specific tumors.

1) Immunotherapy (checkpoint inhibitors)

Checkpoint inhibitors help the immune system recognize and attack cancer. For many people, immunotherapy is the backbone of metastatic melanoma treatment today.

Common checkpoint inhibitor approaches include:

• Anti–PD-1 therapy (often used alone): examples include pembrolizumab or nivolumab.
• Combination immunotherapy (more intense, often higher response but more side effects): nivolumab + ipilimumab is a well-known pairing.
• Dual immunotherapy with LAG-3 + PD-1: nivolumab + relatlimab is another option used in some first-line settings.

Example (real-world decision-making): If someone has widespread disease but is otherwise stable, a PD-1–based regimen might be chosen to aim for long-term control. If the disease is aggressive and needs a strong upfront push, a combination may be consideredbalancing potential benefit against higher risk of immune-related side effects.

2) Targeted therapy (for BRAF-mutant melanoma)

If the tumor has a BRAF V600 mutation, targeted therapy can be a powerful option. These treatments often combine a BRAF inhibitor with a MEK inhibitor. The goal is to block signals that drive tumor growth.

Why targeted therapy is different: It can work quicklysometimes helpful when symptoms are severe or the cancer burden is high. However, responses may not last as long as the best immunotherapy responses for some patients, so sequencing (which treatment first) is an important conversation.

Example scenario: A patient with BRAF-mutant melanoma who has significant symptoms (like rapidly worsening lung symptoms) might start with targeted therapy to stabilize quickly, then transition to immunotherapy depending on response and overall plan.

3) Surgery (in selected cases)

Surgery isn’t “off the table” just because melanoma is metastatic. Some people have oligometastatic disease (a small number of metastatic tumors). Removing one or a few tumors may help control symptoms or reduce total disease burdenespecially when combined with systemic therapy.

4) Radiation therapy (including stereotactic radiosurgery)

Radiation can help with:

• Brain metastases (often with focused treatments like stereotactic radiosurgery)
• Bone pain from metastases
• Bleeding, compression, or other local symptoms

Radiation is often used alongside immunotherapy or targeted therapy, depending on the clinical situation.

5) Intralesional therapy (for accessible tumors)

If melanoma lesions are reachable (on or near the skin, or in certain lymph nodes), doctors may use intralesional treatmentstherapy injected directly into tumors. One well-known option is T-VEC (an oncolytic virus therapy) for certain settings. It’s not for everyone, but it can be part of a broader strategy.

6) Tumor-infiltrating lymphocyte (TIL) therapy

TIL therapy is a newer cellular immunotherapy option for some people with advanced melanoma, typically after other treatments (like PD-1 therapy) have already been tried. In simple terms, doctors collect immune cells from a patient’s tumor, grow large numbers of them, then give them back to help fight cancer.

This approach can be a meaningful option in later lines of therapy for selected patients, and it’s a big reason many melanoma specialists emphasize treatment at (or consultation with) a center experienced in advanced melanoma care.

7) Clinical trials

Clinical trials can provide access to emerging treatments and combinations. Trials may focus on:

• New immunotherapy targets or combinations
• Personalized vaccines or cell therapies
• Approaches for brain metastases
• Better sequencing of targeted therapy and immunotherapy

If you hear “clinical trial,” don’t translate it as “guinea pig.” In oncology, trials are often how patients access tomorrow’s best options todayunder careful monitoring and strict safety rules.

8) Supportive (palliative) care

Supportive care is not “giving up.” It’s specialized care that helps manage symptoms, treatment side effects, sleep, appetite, pain, stress, and quality of lifeoften alongside active cancer treatment. Many studies across cancer types show that early supportive care can improve day-to-day well-being and help people stay on treatment.

Side effects: what to watch for

Metastatic melanoma treatments can be life-changingbut they can also come with side effects. Knowing what’s common (and what’s urgent) helps you act quickly.

Immunotherapy side effects

Checkpoint inhibitors can cause immune-related side effects, meaning the immune system gets a little too enthusiastic and starts irritating healthy tissues. Possible issues can include inflammation of the skin, colon, liver, lungs, hormone glands, or other organs.

Call your care team quickly if you develop new severe diarrhea, shortness of breath, chest pain, significant rash, yellowing of eyes/skin, or unusual weakness/confusion. Early treatment can prevent bigger problems.

Targeted therapy side effects

BRAF/MEK inhibitor therapy can cause fever, fatigue, rash, joint pain, and other effects. Fevers can be significant and sometimes require medication adjustments. Always report persistent fever or dehydration symptoms promptly.

Outlook (prognosis) for metastatic melanoma

Outlook depends on many factors, including where the melanoma has spread, how much disease is present, LDH levels, overall health, andmost importantlyhow the cancer responds to treatment.

Population survival statistics: Large U.S. datasets show that melanoma diagnosed at a “distant” stage has a 5-year relative survival around the mid-30% range. This is a broad statistic that combines many different situations and treatment histories, so it can’t predict what will happen for one personbut it does show how much outcomes have improved compared to earlier eras.

Long-term responders exist: Modern immunotherapy has created a group of patients who achieve long-lasting control. Long follow-up data from major immunotherapy combinations show that some patients remain alive and cancer-free many years latersomething that was incredibly rare before checkpoint inhibitors.

Factors that can affect prognosis

• Metastasis location: Brain and liver metastases can be more challenging than skin/lymph node-only spread.
• Number of metastatic sites: Limited metastases may be approached differently than widespread disease.
• LDH level: Higher LDH can be associated with a more difficult prognosis in stage IV melanoma.
• Tumor biology: Mutations (like BRAF), growth rate, and immune environment may influence treatment response.
• Performance status: How well someone can do daily activities often guides which treatments are safest and most effective.

A realistic (and hopeful) takeaway: “Metastatic” is serious, but it’s also a place where medicine has made dramatic progress. Many patients now have multiple effective options, including second-line and third-line treatments if the first plan stops working.

Living with metastatic melanoma: practical tips that matter

Metastatic melanoma care isn’t just about picking a drug. It’s also about navigating a new routineand keeping your life from shrinking down to a calendar of scans and side effects.

Stay organized (future you will thank you)

• Keep a list of medications, doses, and start dates.
• Track symptoms and side effects daily (even short notes help).
• Write questions before appointmentsscan-day brain is not reliable memory.

Protect your skin and keep up with checks

• Use broad-spectrum sunscreen, seek shade, and avoid tanning beds.
• Do regular skin self-checks and keep dermatology visits as recommended.
• Ask your team how often you should have full-body skin exams.

Support is a treatment tool, too

Living with advanced cancer can bring anxiety, fear, anger, and griefsometimes all before lunch. Support can include oncology social workers, counseling, support groups, spiritual care, or simply a trusted person who comes to appointments and takes notes.

Questions to ask your oncology team

• Where has the melanoma spread, and how much disease is present?
• Has my tumor been tested for mutations (like BRAF)? What were the results?
• What are the goals of treatment right now (shrink tumors, long-term control, symptom relief)?
• What are the first-line options for my situation, and why?
• What side effects should I watch for, and what symptoms are urgent?
• How will we measure response (scan schedule, blood work, symptoms)?
• If this treatment stops working, what are the next options?
• Should I consider a second opinion or a melanoma specialty center consult?
• Are clinical trials appropriate for me now or later?

Bottom line

Metastatic melanoma is a challenging diagnosis, but it’s also an area of cancer care where treatment has evolved fast. Many people are treated with immunotherapy, targeted therapy (when BRAF mutations are present), or combinationsoften alongside surgery or radiation when specific tumors need local control. Prognosis varies widely, and while population statistics provide context, individual outcomes can be much better than older expectationsespecially for people who respond well to modern systemic therapies.

Experiences with metastatic melanoma (what patients often describe)

Note: Everyone’s story is different. The experiences below reflect patterns many patients and caregivers commonly describeespecially in support groups and cancer center education settings. Use this as “what it can feel like,” not a prediction of what you will feel.

1) The symptom whiplash: “How did we get from a mole to this?”
Many people describe the shock of learning melanoma has spread, especially if the original skin lesion seemed small, painless, or “not that dramatic.” Some say the first clue wasn’t even skin-relatedlike a persistent cough, unexplained fatigue, or headaches that finally crossed the line from annoying to concerning. The emotional jump from “I’m probably fine” to “I need an oncology team” can feel surreal. A common coping strategy is focusing on concrete next steps: get the biopsy, get the scans, get the mutation testing, and then talk optionsone decision at a time.

2) Scan life: living in 3-month chapters
A frequent theme is how quickly life becomes organized around imaging: CTs, PET scans, brain MRIs. Patients often talk about “scanxiety”the stress in the days leading up to results. Some people build routines to soften it: scheduling a comforting activity after scans, bringing a friend, planning simple distractions, or asking the care team how (and when) results will be delivered. Others find it helpful to request plain-language explanations: “What changed?” “Is this a meaningful change?” “Does this alter the plan?” Clear communication can reduce the mental spirals that scans sometimes trigger.

3) Immunotherapy: hope with a side of unpredictability
Patients often describe immunotherapy as both empowering and weirdly mysterious. Empowering because it can lead to major responseseven long-lasting control. Mysterious because the timeline and side effects can be unpredictable. Some people feel mostly normal on PD-1 therapy and keep working, parenting, traveling, or doing daily routines with minimal interruption. Others develop immune-related side effects that require steroids, treatment pauses, or specialist visits (like endocrinology). Many say the key is learning to report symptoms earlybefore “minor” becomes “complicated.” The common lesson: don’t tough it out silently. Oncology teams would rather hear from you on a Tuesday afternoon than meet you in an emergency room on Saturday night.

4) Targeted therapy: fast results, active management
People with BRAF-mutant melanoma sometimes describe targeted therapy as a “rapid reset”symptoms can improve quickly when treatment is effective. But they also mention the need for active side-effect management, especially fevers, rash, or fatigue. Some learn practical tricks: staying hydrated, monitoring temperature, knowing when to call, and keeping a plan for fever days. Many say it feels like a partnership: the medication does its part, and the patient (with the care team) does a lot of day-to-day steering to keep side effects under control.

5) The identity shift: “I’m still me, but now I’m also a patient”
Beyond the medical side, people often talk about the social and emotional changes: learning a new vocabulary, explaining things to family, deciding what to share with coworkers, and dealing with well-meaning but unhelpful comments (“Have you tried… kale?”). Some patients find support groups helpful because they can speak honestly without needing to translate. Others prefer one-on-one counseling or private coping strategies like journaling, creative hobbies, or exercise adapted to energy levels. A very common turning point is realizing that asking for help isn’t weaknessit’s strategy.

6) Redefining “outlook”: focusing on control, not certainty
Many patients say the hardest part is uncertainty: treatment can work amazingly well, or it may need adjustments. Over time, people often shift from craving a perfect prediction to aiming for practical goals: controlling disease, protecting quality of life, and keeping meaningful plans on the calendar. Some celebrate small winsstable scans, fewer symptoms, a good lab result, a weekend trip, a child’s school event. Others lean into big-picture hope, especially knowing there are more options now than ever: different immunotherapy combinations, targeted approaches, cellular therapies, clinical trials, and localized treatments for specific metastases.

If you’re supporting someone with metastatic melanoma: patients often say the most helpful things are surprisingly simplerides to appointments, help with meals, someone to take notes, and a steady presence that doesn’t try to “fix” emotions. Sometimes the best support is: “I’m here. What do you need today?”

The post Metastatic melanoma: Symptoms, treatment, and outlook appeared first on Global Travel Notes.